Refine by
-
Letter to Congressional Committee Leadership on Research and Innovation & Criminal Justice
Letter to House and Senate Appropriations Committee leadership requesting $35 million for the U.S. Centers for Disease Control and Prevention (CDC), $25 million for the National Institutes of Health and $1 million for the National Institute of Justice to conduct public health research into firearm morbidity and mortality prevention. -
Interpersonal Therapy for Depression During Pregnancy
Providing brief and recurrent interpersonal therapy may be an effective strategy in reducing depressive symptoms during pregnancy. A randomized clinical trial of 234 pregnant adults with elevated depression symptoms treated patients with either enhanced usual care (EUC) or MomCare. EUC consists of maternity support services with optional mental health counseling while MomCare is a culturally relevant intervention of weekly, interpersonal therapy sessions with psychoeducation. Overall, participants in the MomCare group showed a greater reduction in depressive scores compared to participants receiving EUC. Future research will focus on whether children born to individuals undergoing the MomCare intervention experience a reduction in risk for their own mental health concerns. To learn more, see the study in JAMA Psychiatry. -
Initial Research on TikTok’s Mental Health Impacts
Current research suggests social media overall may have positive and negative impacts on mental health. A novel study interviewed 16 participants about their experience interacting with mental health content on TikTok to learn about the platform’s specific impacts. The most commonly reported benefits were a sense of self-discovery and social support through a virtual community. While users noted that mental health information was easily accessible, they worried about its credibility. Researchers also warn that the algorithm-driven platform may continuously serve users unwanted or harmful content. Further research is needed to better understand how TikTok affects mental health, including how to maintain its benefits while mitigating drawbacks. To learn more, see the study here. -
Letter to FDA Commissioner & HHS Secretary on Research and Treatment Innovation
Letter to HHS Secretary Becerra and FDA Commissioner Califf urging the Federal Drug Administration FDA to reissue its ban of electrical stimulation devices used to treat self-injurious or aggressive behavior. -
Thriving on the Bipolar Spectrum: Changing the Narrative with Stories of Lived Experience
We’re now on a shared mission to end the stigma, maximize healing and save lives by spreading education and inspiration. -
FDA Approves Over-the-Counter Naloxone Spray
Naloxone, commonly known under the brand name Narcan, is a medication that rapidly reverses the effects of an opioid overdose. Until this year, all forms of naloxone had been designated as prescription-only. After hearing from an expert advisory panel, the U.S. Food and Drug Administration (FDA) approved the sale of over-the-counter naloxone hydrocholoride nasal spray nationwide in March. The decision removes a critical access barrier to the life-saving treatment, thereby reducing overdose deaths and the associated stigma. Implementation will be ongoing in the coming months with pending information on the cost of the medication. To learn more, see the news release from the FDA. -
Survey Suggests Better Integration of 988 with Mobile Crisis Teams May Be Needed
Nearly a year since the launch of the 988 Suicide and Crisis Lifeline, there is still uncertainty about its role within the mental health system. One goal of 988 is to connect callers in urgent need of support with a mobile crisis team (MCT) in their area. However, a national survey of MCT personnel found that only a third of respondents (32%) indicated that their MCT could be reached by 988. Respondents were most likely to report that their MCT could be dispatched by calling the MCT directly (65%) or through 911 (54%). The findings highlight the need to continuously evaluate and improve 988 integration in communities, as well as the importance of communicating how individuals can reach an MCT if needed. To learn more, see the study in Psychiatric Services. -
Regulatory Comment to the Office of Science and Technology Policy on Criminal Justice and Research and Treatment Innovation
Regulatory comment to White House Office of Science & Technology Policy in response to the RFI on “Advancing Effective, Accountable Policing and Criminal Justice Practices to Enhance Public Trust and Public Safety.” -
National Poll Finds Pets Support Mental Health
The latest results from the APA’s Healthy Minds Monthly Poll suggest that pets are beneficial for owners’ mental health. In a national poll of 2,200 American adults, more than half of all pet owners reported that their pets positively impact their mental health, including 87% of dog owners and 86% of cat owners. Among respondents who indicated a positive impact, over two thirds identified specific benefits such as reduced stress and anxiety (69%), unconditional love and support (69%), and companionship (69%). Despite associated worries of pet ownership, the findings suggest that having a pet is a protective factor for mental health and wellbeing. To learn more, see the poll results from the APA. -
Early Treatment Initiation May Help Reduce Self-Harm in Youth and Young Adults with First-Episode Psychosis
Early intervention has been identified as crucial for improving outcomes in the treatment of individuals experiencing first-episode psychosis (FEP). A retrospective longitudinal, cohort study of Medicaid claims data for over 6,000 youth and young adults with FEP examined if early treatment initiation and engagement helped reduce deliberate self-harm (DSH). While treatment initiation within 14 days of diagnosis was found to significantly decrease the risk of DSH, treatment engagement within 90 days of diagnosis was not. Given such findings and that individuals with psychosis are at an increased risk for suicide, developing new treatment plans specifically targeting self-harm could help better meet the needs of patients with FEP. To learn more, see the study in Psychiatric Services.
